Cargando…
Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer
Targeting the immune system has emerged as an effective therapeutic strategy for the treatment of various tumor types, including Head and Neck Squamous Cell Carcinoma (HNSCC) and Non-small-Cell Lung Cancer (NSCLC), and checkpoint inhibitors have shown to improve patient survival in these tumor types...
Autores principales: | Saiz-Ladera, Cristina, Baliu-Piqué, Mariona, Cimas, Francisco J., Manzano, Aránzazu, García-Barberán, Vanesa, Camarero, Santiago Cabezas, Hinojal, Gonzalo Fernández, Pandiella, Atanasio, Győrffy, Balázs, Stewart, David, Cruz-Hernández, Juan J., Pérez-Segura, Pedro, Ocana, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527851/ https://www.ncbi.nlm.nih.gov/pubmed/34692491 http://dx.doi.org/10.3389/fonc.2021.714550 |
Ejemplares similares
-
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
por: Alcaraz-Sanabria, Ana, et al.
Publicado: (2020) -
A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors
por: Pérez-Pena, Javier, et al.
Publicado: (2019) -
Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1
por: Cimas, Francisco J., et al.
Publicado: (2020) -
Breast Cancer Heterogeneity and Response to Novel Therapeutics
por: Baliu-Piqué, Mariona, et al.
Publicado: (2020) -
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation
por: Noblejas-López, María del Mar, et al.
Publicado: (2021)